VENITI

veniti-logo

VENITI is the first medical device company developing a suite of innovative technology and solutions that will provide comprehensive treatment across the venous disease continuum. Venous disease refers to all conditions related to or caused by veins that become diseased or abnormal. This encompasses a broad set of maladies. The venous disease cycle begins when vein walls become weak or damaged, or the valves are stretched or injured, and can no longer prevent reflux (backward flow of blood). ... Once the veins lose their ability to convey blood without reflux, the progressive venous disease cycle has begun. This is commonly referred to as chronic venous insufficiency, or CVI. The blood will begin to back up into the peripheral veins, causing venous hypertension, potential thrombosis (clotting), and leading to even more damage of the vein walls and valves. This in turn leads to more reflux. The VENITI team of experts in science, technology and business are currently developing the VENITI VICI VENOUS STENT® System. Through this, and other, innovative technology, VENITI will achieve results that sets it apart in addressing the challenges specific to the venous system and venous disease.

#SimilarOrganizations #People #Financial #Website #More

VENITI

Social Links:

Industry:
Biotechnology Health Care Medical Medical Device

Founded:
2010-01-01

Address:
Fremont, California, United States

Country:
United States

Website Url:
http://www.venitimedical.com

Total Employee:
11+

Status:
Closed

Contact:
(314) 282-3753

Email Addresses:
[email protected]

Total Funding:
65.22 M USD

Technology used in webpage:
Domain Not Resolving Cloudflare Hosting Cloudflare DNS


Similar Organizations

alung-technologies-logo

ALung Technologies

ALung Technologies develops medical gas exchange devices for the treatment of acute and chronic respiratory disorders.

echo-therapeutics-logo

Echo Therapeutics

Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.

intarcia-therapeutics-logo

Intarcia Therapeutics

Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.

mercator-medsystems-logo

Mercator MedSystems

Mercator MedSystems develops site-specific delivery devices for the treatment of vascular, oncologic, and regenerative diseases.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

prolocor-logo

Prolocor

Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.

sprout-pharmaceuticals-logo

Sprout Pharmaceuticals

Sprout Pharmaceuticals is a medical company that develops products for the treatment of female sexual dysfunction.

telcare-logo

Telcare

Telcare develops machine-2-machine cellular technology that wirelessly connects patients and physicians to cure chronic illnesses.

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.


Current Advisors List

michael-liang_image

Michael Liang Board of Directors @ Veniti
Board_member

glen-a-kashuba_image

Glen A. Kashuba Board of Directors @ Veniti
Board_member
2011-10-01

Founder


sean-morris_image

Sean Morris

Acquisitions List

Date Company Article Price
2011-01-01 Varix Medical Varix Medical acquired by Veniti N/A

Investors List

tekla-capital-management_image

Tekla Capital Management

Tekla Capital Management investment in Series C - Veniti

life-sciences-alternative-funding_image

Life Sciences Alternative Funding

Life Sciences Alternative Funding investment in Debt Financing - Veniti

baird-capital_image

Baird Capital

Baird Capital investment in Series C - Veniti

vectis-healthcare-life-sciences-fund_image

Vectis Healthcare & Life Sciences Fund

Vectis Healthcare & Life Sciences Fund investment in Series C - Veniti

holton-capital-group-llc_image

Holton Capital Group

Holton Capital Group investment in Series C - Veniti

volcano-capital_image

Volcano Capital

Volcano Capital investment in Series C - Veniti

prolog-ventures_image

Prolog Ventures

Prolog Ventures investment in Series C - Veniti

cd-venture_image

CD-Venture

CD-Venture investment in Series C - Veniti

nitinol-devices-components_image

Nitinol Devices & Components

Nitinol Devices & Components investment in Series C - Veniti

cultivation-capital_image

Cultivation Capital

Cultivation Capital investment in Venture Round - Veniti

Official Site Inspections

http://www.venitimedical.com

Unable to get host informations!!!

Loading ...

More informations about "Veniti"

Veniti - Crunchbase Company Profile & Funding

Veniti develops medical devices for the treatment of chronic venous insufficiency disease. View contacts for Veniti to access new leads and connect with decision-makers. VENITI is the first medical device company developing a suite of …See details»

Veniti, Inc. in Maple Grove, MN - (314) 888-9225 - Company Profile

Veniti, Inc. is in the Medical Research business. View competitors, revenue, employees, website and phone number.See details»

Veniti, Inc. Company Profile | Maple Grove, MN | Competitors ...

Find company research, competitor information, contact details & financial data for Veniti, Inc. of Maple Grove, MN. Get the latest business insights from Dun & Bradstreet.See details»

Veniti, Inc. - Radcliffe Vascular

VENITI is the first medical device company developing a suite of innovative technology and solutions that will provide comprehensive treatment across the venous disease continuum.See details»

VENITI, Inc. - LinkedIn

VENITI is the first medical device company developing a suite of innovative technology and solutions that will provide comprehensive treatment across the venous disease continuum. …See details»

Veniti | VentureRadar

Website: http://www.venitimedical.com. VENITI, Inc. is an early-stage commercialization company that is headquartered in St. Louis, MO and has technical operations in Fremont, CA. Founded …See details»

Veniti Inc - Company Profile and News - Bloomberg Markets

Veniti inc. operates as a medical device company. The Company offers vici venous stent system that is used to treat venous outflow obstruction in the lower extremities and engages in …See details»

Veniti Company Profile 2024: Valuation, Investors, Acquisition

Developer of a medical device designed to cure venous diseases. The company's device is a closed-cell geometry with 24 strut rings and alternating curved bridges work together forming …See details»

Boston Scientific Announces Agreement to Acquire VENITI, Inc.

MARLBOROUGH, Mass., Aug. 8, 2018 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) today announced it has signed an agreement to acquire VENITI, Inc., a privately-held …See details»

Medical Device Startup Veniti Lands $13.5 Million Series A

Mar 8, 2011 · Veniti, a Saint Louis -based medical device company, has raised a $13.5 million Series A round led by Baird Venture Partners, H&Q Healthcare Investors, and H&Q Life …See details»

Boston Scientific to acquire Veniti for $160m - Medical Device …

Boston Scientific has signed an agreement to acquire US-based VICI VENOUS STENT System developer Veniti in a deal valued at $160m. Boston Scientific currently owns a 25% stake in …See details»

Boston Scientific acquires remainder of vein stent maker Veniti in ...

Aug 8, 2018 · Boston Scientific plans to fully acquire stent developer Veniti—which it already owns 25% of—by buying up the remaining stake in the startup for $108 million upfront, plus up …See details»

Veni Vidi Vici Veniti Plans to Conquer the Venous Disease Device …

Apr 1, 2015 · Veniti, a company located in St. Louis, Missouri, is poised and ready to stake its claim within the vein device market with a trio of products planned for rollout over the course of …See details»

Boston Scientific inks Veniti takeover to access untapped stent …

Aug 9, 2018 · Boston Scientific is set to acquire Veniti for its device to treat venous obstructive disease. The deal will see Boston Scientific pay $108 million in cash upfront and commit to up …See details»

Boston Scientific to distribute Veniti VICI Venous Stent

Nov 2, 2017 · Veniti Inc., a research company in the advancement of treatment for deep venous disease, has announced that Boston Scientific will distribute its VICI Venous Stent under a …See details»

VENITI® Completes First Use Of VICI VERTO VENOUS STENT™, …

Apr 21, 2016 · VENITI, Inc. is dedicated to advancing the treatment of venous disease through clinical research and innovative technology and solutions. VENITI partners with leading …See details»

Veniti announces first uses of Veniti Vici Venous Stent System

Jan 27, 2014 · Veniti announced on 23 January 2014 that patients in the European Union (EU) were successfully treated for symptomatic venous outflow obstruction of the lower extremities …See details»

VENITI completes first use of VICI VERTO VENOUS STENT system

Apr 22, 2016 · “It is encouraging to see the team at VENITI and others in industry working with physicians to develop new products like the VICI VERTO VENOUS STENT which address the …See details»

VENITI® Completes First Use Of VICI VERTO VENOUS STENT™, …

Apr 22, 2016 · VENITI, Inc., the leader in the advancement of treatment for venous disease, announced today the successful treatment of the first patient suffering from Post Thrombotic …See details»

Venous stent - VICI VENOUS STENT® - Veniti - MedicalExpo

VENITI is developing a new stent for the venous anatomy, the VENITI Vici Venous Stent. The Vici Venous Stent System is aimed at the treatment of venous outflow obstruction.See details»

linkstock.net © 2022. All rights reserved